Treatment of persistent myoclonic tardive dystonia with verapamil.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 8097657.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A dramatic improvement in a patient with tardive dystonia was obtained with verapamil after the failure of other medicines. The use of verapamil or other calcium-channel blockers should be considered when treating drug-induced movement disorders.
Medical subject headings
- Antipsychotic Agents
- Bipolar Disorder
- Dyskinesia, Drug-Induced
- Dystonia
- Verapamil